Perkins Coie Trust Co - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 398 filers reported holding SEATTLE GENETICS INC in Q4 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.

Quarter-by-quarter ownership
Perkins Coie Trust Co ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2019$9,000
+28.6%
1000.0%0.00%
+33.3%
Q2 2019$7,0000.0%1000.0%0.00%0.0%
Q1 2019$7,000
+16.7%
1000.0%0.00%0.0%
Q4 2018$6,000
-25.0%
1000.0%0.00%
-25.0%
Q3 2018$8,000
+14.3%
1000.0%0.00%
+33.3%
Q2 2018$7,000
+40.0%
1000.0%0.00%
+50.0%
Q1 2018$5,0000.0%1000.0%0.00%0.0%
Q4 2017$5,0000.0%1000.0%0.00%
-33.3%
Q3 2017$5,0000.0%1000.0%0.00%0.0%
Q2 2017$5,000
-16.7%
1000.0%0.00%
-25.0%
Q1 2017$6,000
+20.0%
1000.0%0.00%
+33.3%
Q4 2016$5,0000.0%1000.0%0.00%0.0%
Q3 2016$5,000
+25.0%
1000.0%0.00%0.0%
Q2 2016$4,0000.0%1000.0%0.00%0.0%
Q1 2016$4,0000.0%1000.0%0.00%0.0%
Q4 2015$4,0000.0%1000.0%0.00%0.0%
Q3 2015$4,000
-20.0%
1000.0%0.00%
-25.0%
Q2 2015$5,000
+25.0%
1000.0%0.00%
+33.3%
Q1 2015$4,000
+33.3%
1000.0%0.00%
+50.0%
Q4 2014$3,0001000.00%
Other shareholders
SEATTLE GENETICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Baker Brothers Advisors 51,049,760$3,738,884,00023.93%
Lagoda Investment Management, L.P. 76,873$5,630,0007.16%
Matrix Capital Management Company, LP 3,141,852$230,109,0006.14%
DOMINI IMPACT INVESTMENTS LLC 3,120$229,0003.51%
Opus Point Partners Management, LLC 17,832$1,306,0001.77%
Capital International Sarl 188,200$13,784,0001.72%
EMORY UNIVERSITY 33,368$2,444,0001.72%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 60,900$4,460,0001.65%
CAPITAL GUARDIAN TRUST CO 1,358,254$99,415,0001.32%
Rhenman & Partners Asset Management AB 150,598$11,030,0001.29%
View complete list of SEATTLE GENETICS INC shareholders